JACKSON — A $7.4 billion settlement with Purdue Pharma and the Sackler family became legally effective May 1, and Mississippi is expected to receive $40,958,248.92 over the next 15 years, Attorney General Lynn Fitch announced Friday.
The settlement resolves more than a decade of litigation by state attorneys general over Purdue’s and the Sacklers’ role in the opioid epidemic. Mississippi sued Purdue in December 2015, and Purdue filed for bankruptcy in September 2019 amid widespread litigation, state officials said.
Fifty-five attorneys general representing eligible states and territories signed onto the agreement, which permanently bars the Sacklers from selling opioids in the United States and directs money to addiction treatment, prevention and recovery programs. Purdue’s manufacturing operations transferred May 1 to Knoa Pharma LLC, which will be overseen by a board with no connection to Purdue and will be subject to an independent monitor and restrictions on marketing.
Fitch said, “The opioid epidemic has claimed far too many lives in Mississippi, leaving behind lasting pain. This settlement is another step toward holding accountable those who played a role in this epidemic and toward healing for many Mississippians who lost loved ones.” Her office said the latest agreement brings the total opioid settlement funds secured for Mississippi to more than $400 million and requires the release of more than 30 million documents related to Purdue’s opioid business.
We will provide more information as it becomes available.
